Search the Newsreel

Tailam Tech Construction Sets Board Meeting to Approve Interim Results and Consider Dividend

Greenlam Ind Standalone June 2026 Net Sales at Rs 584.41 crore, up 4.83% Y-o-Y

Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH

(RTTNews) - The following biotech stocks reached a 52-week high on August 11, 2026, driven up by key catalysts such as positive quarterly or full year reports. Alamar Biosciences Inc. (ALMR) Alamar Biosciences is a proteomics company that has develops a liquid biopsy platform …

Projeções de Resultados: Lam Research Corp (LRCX) — LPA e Crescimento de Receita

Greenlam Industries confirms outcome of August 12 analyst meet

Alamar Biosciences (ALMR): Qiming funds report over 10% ownership stake

Qiming funds have reported a significant ownership stake in Alamar Biosciences, Inc. (ALMR) through a Schedule 13G filing. Qiming Corporate GP VI, Ltd and related entities collectively hold 10.2% beneficial ownership, translating to 7,066,573 shares based on 69,311,186 shares outstanding as of April 30, …

JPMORGAN CHASE & CO Trims Lamb Weston Holdings Inc (LW) Stake --

JPMorgan Chase & Co. has reduced its stake in Lamb Weston Holdings Inc. (NYSE: LW) by 5.57%, selling 406,022 shares at $43.18 each, though it still retains over 6.8 million shares. The stock is considered "Modestly Undervalued" with a GF Value of $65.39, despite …

Analyst Estimates: Here's What Brokers Think Of Greenlam Industries Limited (NSE:GREENLAM) After Its First-Quarter Report

Alamar Biosciences Shares (ALMR) Surge 31% as Consumables Drive Gross Margin Up

Alamar Biosciences (ALMR) shares surged 31% after reporting an 82% increase in second-quarter revenue, primarily driven by a 147% surge in consumable sales. Consumables now account for 52.6% of revenue, boosting gross margin to 60%. Despite continued operating losses, the company's strong revenue growth …

Willamette Valley Vineyards launches a $1.75 million stock offering for wine consumers

Alamar Biosciences Q2 Results: Revenue Rises 82% To $29.4 Million

Bronstein, Gewirtz & Grossman, LLC Is Investigating Alnylam Pharmaceuticals, Inc. (ALNY) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alnylam Pharmaceuticals, Inc. (ALNY) after the company lowered its full-year 2026 TTR product sales guidance, causing its stock price to drop significantly. The investigation encourages investors who purchased Alnylam securities to connect with the …

How Lamb Weston Holdings Inc. (LW) Affects Rotational Strategy Timing

The article analyzes Lamb Weston Holdings Inc. (LW) using AI models to provide trading strategies and signal analysis. It indicates weak near-term sentiment but mid-term strength within a broader long-term weak bias, suggesting compelling upside potential due to no resistance levels above the current …

BORUSAN YATIRIM VE PAZARLAMA A.Ş.(BRYAT) TSRS Uyumlu Sürdürülebilirlik Raporu 11 Ağustos 2026

Stifel raises Alamar Biosciences stock price target on earnings beat

Stifel has increased its target price for ALAMAR BIOSCIENCES INC to $32 from $28. This update, reported by Reuters, reflects an analyst's revised valuation for the company. The article emphasizes that the content represents the author's opinion and should not be used as investment …

Why Laramide Resources Ltd. stock is skyrocketing today

Earnings Flash (ALMR) Alamar Biosciences, Inc. Reports Q2 Revenue $29.4M, Vs. FactSet Est of $25.9M

Alamar Biosciences, Inc. (ALMR) announced its second-quarter revenue of $29.4 million, significantly exceeding the FactSet estimate of $25.9 million. This earnings flash highlights the company's financial performance for the recent quarter.

Lambodhara Textiles net profit rises 66% in Q1FY27 on cost cuts

ALAMAR BIOSCIENCES INC : STIFEL RAISES TARGET PRICE TO $32 FROM $28

Stifel has increased its target price for ALAMAR BIOSCIENCES INC to $32 from $28. This update, reported by Reuters, reflects an analyst's revised valuation for the company. The article emphasizes that the content represents the author's opinion and should not be used as investment …

Lam Research Enters Panel-Level Packaging: Is This a Growth Catalyst?

Lam Research Corporation LRCX is expanding its opportunity in advanced packaging as artificial intelligence (AI) chips become larger and more complex. The company seems to be now focusing on the Panel-Level Packaging ("PLP") method. In this connection, it established a Panel-Level Packaging Center of …

Erste Group Bank Lifts Earnings Estimates for Lam Research

Is Lam Research, KLA, or Applied Materials the Best Chip Equipment Buy? Jim Cramer Weighs In

Cramer's Case for the Semiconductor Equipment "Troika" During the August 6 episode of CNBC's Mad Money, host Jim Cramer pointed to the bottleneck in data center memory production and urged investors to focus on the companies building the fabrication machinery. He highlighted Lam Research …

Lam Research Corporation $LRCX Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB significantly reduced its holdings in Lam Research Corporation (NASDAQ:LRCX) by 5.9% in the second quarter, selling 35,142 shares. Despite this, Lam Research remains a substantial part of their investment portfolio. Other institutional investors showed mixed activity, with some acquiring new positions …

Generali Investments Management Co LLC Sells 4,351 Shares of Lam Research Corporation $LRCX

Generali Investments Management Co LLC reduced its stake in Lam Research Corporation by 43.2% in the second quarter, selling 4,351 shares and retaining 5,731 shares valued at $2.48 million. Despite this, Lam Research reported strong quarterly earnings, beating expectations with $1.82 EPS on $6.72 …

Redhawk Wealth Advisors Inc. Purchases 7,613 Shares of Lam Research Corporation $LRCX

Redhawk Wealth Advisors Inc. significantly increased its stake in Lam Research Corporation (NASDAQ:LRCX) by 808.2% in the second quarter, acquiring an additional 7,613 shares to own a total of 8,555 shares valued at $3.7 million. This move is part of a broader trend of …

Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $33.4, Implies 19% Upside

Alamar Biosciences, Inc.'s average 12-month price target has been increased from $31.8 to $33.4 by 5 analysts, with forecasts ranging from $31 to $35 per share. This new target implies approximately 19% potential upside based on the August 10 closing price. The consensus rating …

Tailam Tech Construction flags interim loss amid weak construction demand

Alamar Biosciences, Inc. 2Q 2026: Revenue $29.4M, EPS $(0.22) — 10-Q Summary

Alamar Biosciences, Inc. reported its second-quarter 2026 results, showing revenue of $29.4 million, an 82% increase year-over-year, driven by a surge in consumables sales. Despite this growth, the company recorded a net loss of $13.2 million and a diluted loss per share of $(0.22). …

Lamb Weston Holdings Inc Stock Price Live, Charts & News - The Economic Times

This article provides real-time stock information for Lamb Weston Holdings Inc (LW) on the NYSE, including its current share price, market performance data, and key financial metrics. It details the company's fundamentals, historical returns, and recent quarterly balance sheets, income statements, and cash flow …

Lam Research (LRCX) Gains An AI Supply Chain Tailwind As Customer Demand Surges

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Lam Research (NasdaqGS:LRCX) is in focus as Taiwan Semiconductor reports strong AI driven revenue …

The Manufacturers Life Insurance Company Has $1.38 Million Holdings in Lamb Weston $LW

The Manufacturers Life Insurance Company significantly reduced its stake in Lamb Weston by 68.2% in Q1, selling 70,213 shares but still holding 32,695 shares valued at $1.38 million. Lamb Weston reported strong Q1 earnings, surpassing revenue and EPS estimates, and declared a quarterly dividend …

Alamos Gold Inc. (NYSE:AGI) Given Average Rating of "Moderate Buy" by Analysts

Quantinno Capital Management LP Grows Holdings in Alamos Gold Inc. $AGI

Alamar Biosciences (ALMR) Earnings Date and Reports 2026

Lambodhara Textiles Ltd is Rated Sell

Alamar outlines $116M-$120M 2026 revenue outlook while targeting 100+ instruments and $400,000+ pull-through

Earnings Call Insights: Alamar Biosciences (ALMR) Q2 2026 MANAGEMENT VIEW * “Q2 2026 was a strong quarter that reflects the momentum of our business,” said Co-Founder, Chairman & CEO Yuling Luo, highlighting that “Total revenue grew 82% year-over-year,” that “Consumable revenue accounted for 53% …